Literature DB >> 12709812

Spasmodic dysphonia combined with insufficient glottic closure by phonation.

Z Kaszás1, G Lichtenberger, K Mészáros, J Falvai.   

Abstract

The authors describe the case history of a patient who suffered from symptoms deriving from two different origins. The patient's voice was spasmodic dysphonia-like interrupted and pressed. At the same time, his voice was powerless, too. The reason for this was that besides the spasmodic dysphonia caused by hyperkinesis, an incomplete closure of the vocal cords during phonation in the middle third was present. It was caused by the atrophy of the vocal cords. In order to eliminate the symptoms, initially we injected 25 IU Botox into the left vocal cord transcutaneously under the direction of EMG control. It resulted in a fluent, though breathy voice. In order to manage the closing insufficiency during phonation, we performed lipoaugmentation on the left vocal cord under high-frequency jet anaesthesia. The result of the two-step procedure was a fluent and clear voice. The speech without interruption lasted for 5 months, until the drug was eliminated. Of course, to prolong the result, the Botox injection should be repeated.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12709812     DOI: 10.1007/s00405-003-0604-0

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  7 in total

1.  [Vocal capabilities of nonprofessional singers evaluated by measurement and superimposition of their speaking, shouting and singing voice range profiles].

Authors:  T Hacki
Journal:  HNO       Date:  1999-09       Impact factor: 1.284

2.  Treatment of speech and voice disorders with botulinum toxin.

Authors:  C L Ludlow
Journal:  JAMA       Date:  1990-11-28       Impact factor: 56.272

Review 3.  Therapeutic uses of botulinum toxin.

Authors:  J Jankovic; M F Brin
Journal:  N Engl J Med       Date:  1991-04-25       Impact factor: 91.245

4.  Recurrent laryngeal nerve section for spastic dysphonia.

Authors:  H H Dedo
Journal:  Ann Otol Rhinol Laryngol       Date:  1976 Jul-Aug       Impact factor: 1.547

5.  Botulinum toxin (BOTOX) for the treatment of "spastic dysphonia" as part of a trial of toxin injections for the treatment of other cranial dystonias.

Authors:  A Blitzer; M F Brin; S Fahn; D Lange; R E Lovelace
Journal:  Laryngoscope       Date:  1986-11       Impact factor: 3.325

6.  Selective laryngeal adductor denervation-reinnervation: a new surgical treatment for adductor spasmodic dysphonia.

Authors:  G S Berke; K E Blackwell; B R Gerratt; A Verneil; K S Jackson; J A Sercarz
Journal:  Ann Otol Rhinol Laryngol       Date:  1999-03       Impact factor: 1.547

7.  [External vocal cord medialization: functional outcome].

Authors:  G Friedrich
Journal:  Laryngorhinootologie       Date:  1998-01       Impact factor: 1.057

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.